The expression of TNF-α converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction

European Journal of Clinical Investigation

Volumn 38, Issue 2, 2008, Pages 97-105

  Satoh, M ^a   Ishikawa, Y ^a   Itoh, T ^a   Minami, Y ^a   Takahashi, Y ^a   Nakamura, M ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Immunohistochemistry; Monocyte; Real time PCR

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; AORTA; ARTICLE; ASPIRATION CATHETER; CARDIAC PATIENT; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE; STABLE ANGINA PECTORIS; THROMBOSIS; THROMBUS;

ACUTE DISEASE; ADAM PROTEINS; AGED; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 38449095442     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01912.x     Document Type: Article

References (32)

1. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G et al. Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 2005 111 (7 863 70.
2. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000 101 (18 2149 53.
3. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004 110 (20 3221 8.
4. Shimoda Y, Satoh M, Nakamura M, Akatsu T, Hiramori K. Activated tumour necrosis factor-α shedding process is associated with in-hospital complication in patients with acute myocardial infarction. Clin Sci (Lond) 2005 108 (4 339 47.
5. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997 385 (6618 729 33.
6. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 1997 385 (6618 733 6.
7. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005 111 (11 1355 61.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 (1 156 9.
9. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003 10 (1 133 9.
10. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995 92 (3 657 71.
11. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994 89 (1 36 44.
12. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005 45 (10 1585 93.
13. Libby P. Inflammation in atherosclerosis. Nature 2002 420 (6917 868 74.
14. Botto N, Sbrana S, Trianni G, Andreassi MG, Ravani M, Rizza A et al. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for 'no-reflow' phenomenon? Int J Cardiol 2007 117 (1 123 30.
15. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001 21 (12 1876 90.
16. Aggarwal A, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. Am J Cardiol 2004 93 (1 6 9.
17. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002 39 (2 241 6.
18. Brånén L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004 24 (11 2137 42.
19. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995 92 (2 402 6.
20. Boyle JJ, Weissberg PL, Bennett MR. Tumor necrosis factor- promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanism. Arteriosler Thromb Vasc Biol 2003 23 (9 1553 8.
21. Hansson GK. Immune mechanism in atherosclerosis. Arteriosler Thromb Vasc Biol 2001 21 (12 1876 90.
22. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991 3 (3 189 94.
23. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990 145 (5 1430 4.
24. Jensen JC, Buresh C, Norton JA. Lactic acidosis increases tumor necrosis factor secretion and transcription in vitro. J Surg Res 1990 49 (4 350 3.
25. Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arteriosler Thromb Vasc Biol 2001 21 (9 1402 7.
26. Bozkurt B, Kribbs SB, Clubb FJ Jr., Michael LH, Didenko VV, Hornsby PJ et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998 97 (14 1382 91.
27. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A et al. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 1999 99 (11 1492 8.
28. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK et al. Combination of tumor necrosis factor-α ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 2005 97 (4 380 90.
29. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC et al. An essential role for ectodomain shedding in mammalian development. Science 1998 282 (5392 1281 4.
30. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003 19: 41 (4 Suppl. S): 15S 22S.
31. Pasterkamp G, de Kleijn DP, Borst C. Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res 2000 45 (4 843 52.
32. Li H, Liang J, Castrillon DH, DePinho RA, Olson EN, Liu ZP. FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2007 27 (7 2676 86.